Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 26, 2013, Pages 10812-10817

  Dodge, James C ^a   Treleaven, Christopher M ^a   Fidler, Jonathan A ^a   Tamsett, Thomas J ^a   Bao, Channa ^a   Searles, Michelle ^a   Taksir, Tatyana V ^a   Misra, Kuma ^a   Sidman, Richard L ^b   Cheng, Seng H ^a   Shihabuddin, Lamya S ^a  

^a SANOFI   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Carbonic anhydrase; Electrolyte; Glucagon; Glycoproteins; Motor neuron disease

Indexed keywords

ALPHA GLUCOSIDASE; COPPER ZINC SUPEROXIDE DISMUTASE; COPPER ZINC SUPEROXIDE DISMUTASE 1; GLYCOGEN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; METABOLIC ACIDOSIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

CARBONIC ANHYDRASE; ELECTROLYTE; GLUCAGON; GLYCOPROTEINS; MOTOR NEURON DISEASE;

ACIDOSIS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLYCOGEN; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; SUPEROXIDE DISMUTASE;

MUS; MUS MUSCULUS;

EID: 84879528008     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308421110     Document Type: Article

References (46)

1. Rosen DR (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364(6435):362.
2. Gurney ME, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264(5166):1772-1775.
3. Bruijn LI, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27:723-749.
4. Teng YD, et al. (2012) Multimodal actions of neural stem cells in a mouse model of ALS: A meta-analysis. Science Transl Med 4(165):165ra164.
5. Ames A, 3rd, Maynard KI, Kaplan S (1995) Protection against CNS ischemia by temporary interruption of function-related processes of neurons. J Cereb Blood Flow Metab 15(3): 433-439.
6. Arias RL, et al. (2008) Amiloride is neuroprotective in an MPTP model of Parkinson's disease. Neurobiol Dis 31(3):334-341.
7. Friese MA, et al. (2007) Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system. Nat Med 13(12):1483-1489.
8. Swanson RA, Farrell K, Simon RP (1995) Acidosis causes failure of astrocyte glutamate uptake during hypoxia. J Cereb Blood Flow Metab 15(3):417-424.
9. Khan NA, Guevara P, Sotelo J (1989) Influence of in vitro lactic acidosis on central nervous system neurons. Pathol Biol (Paris) 37(6):725-729.
10. Morihata H, Nakamura F, Tsutada T, Kuno M (2000) Potentiation of a voltage-gated proton current in acidosis-induced swelling of rat microglia. J Neurosci 20(19):7220-7227.
11. Aoyama K, et al. (2005) Acidosis causes endoplasmic reticulum stress and caspase- 12-mediated astrocyte death. J Cereb Blood Flow Metab 25(3):358-370.
12. Ereci-nska M, Nelson D, Dagani F, Deas J, Silver IA (1993) Relations between intracellular ions and energy metabolism under acidotic conditions: A study with nigericin in synaptosomes, neurons, and C6 glioma cells. J Neurochem 61(4):1356-1368.
13. Kirby J, et al. (2011) Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 134(Pt 2):506-517.
14. Behan AT, et al. (2013) Acidotoxicity and acid-sensing ion channels contribute to motoneuron degeneration. Cell Death Differ 20(4):589-598.
15. Rinaldi S, De Gaudio AR (2005) Strong ion difference and strong anion gap: The Stewart approach to acid base disturbances. Curr Anaesth Crit Care 16(6):395-402.
16. Kaplan LJ, Kellum JA (2004) Initial pH, base deficit, lactate, anion gap, strong ion difference, and strong ion gap predict outcome from major vascular injury. Crit Care Med 32(5):1120-1124.
17. Kaplan LJ, Kellum JA (2010) Fluids, pH, ions and electrolytes. Curr Opin Crit Care 16(4): 323-331.
18. Sestoft L, Bartels PD (1983) Biochemistry and differential diagnosis of metabolic acidoses. Clin Endocrinol Metab 12(2):287-302.
19. Ferraiuolo L, et al. (2011) Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 134(Pt 9):2627-2641.
20. Bickler PE, Litt L, Banville DL, Severinghaus JW (1988) Effects of acetazolamide on cerebral acid-base balance. J Appl Physiol 65(1):422-427.
21. Heuser D, Astrup J, Lassen NA, Betz BE (1975) Brain carbonic acid acidosis after acetazolamide. Acta Physiol Scand 93(3):385-390.
22. Hirshhorn R, Reuser AJJ (2001) Glycogen storage disease type II: Acid alpha-glucosidase (acid maltase) deficiency. The Metabolic and Molecular Bases of Inherited Disease, eds Scriver CA, Beaudet AL, Valle D, Sly WS (McGraw-Hill, New York), 8th Ed, pp 3389-3420.
23. Sidman RL, et al. (2008) Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice. J Neuropathol Exp Neurol 67(8):803-818.
24. Herscovics A (1999) Importance of glycosidases in mammalian glycoprotein biosynthesis. Biochim Biophys Acta 1473(1):96-107.
25. Haidet-Phillips AM, et al. (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29(9):824-828.
26. Tandan R, et al. (1996) A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data. Neurology 47(5): 1220-1226.
27. CudkowiczME, et al.; Northeast ALS Consortium (2003) A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology 61(4):456-464.
28. Chesler M (1990) The regulation and modulation of pH in the nervous system. Prog Neurobiol 34(5):401-427.
29. Tankersley CG, Haenggeli C, Rothstein JD (2007) Respiratory impairment in a mouse model of amyotrophic lateral sclerosis. J Appl Physiol 102(3):926-932.
30. Ainslie PN, Duffin J (2009) Integration of cerebrovascular CO2 reactivity and chemoreflex control of breathing: Mechanisms of regulation, measurement, and interpretation. Am J Physiol Regul Integr Comp Physiol 296(5):R1473-R1495.
31. Zhong Z, et al. (2008) ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11(4):420-422.
32. Miyazaki K, et al. (2012) Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice. J Cereb Blood Flow Metab 32(3):456-467.
33. Fidler JA, et al. (2011) Disease progression in a mouse model of amyotrophic lateral sclerosis: The influence of chronic stress and corticosterone. FASEB J 25(12):4369-4377.
34. Chang Y, et al. (2008) Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PLoS ONE 3(8):e2849.
35. Newman GC, Hospod FE, Schissel SL (1991) Ischemic brain slice glucose utilization: Effects of slice thickness, acidosis, and K+. J Cereb Blood Flow Metab 11(3):398-406.
36. Uhernik AL, Tucker C, Smith JP (2011) Control of MCT1 function in cerebrovascular endothelial cells by intracellular pH. Brain Res 1376:10-22.
37. Dalakas MC, Hatazawa J, Brooks RA, Di Chiro G (1987) Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann Neurol 22(5):580-586.
38. Browne SE, et al. (2006) Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol Dis 22(3):599-610.
39. Godoy JM, Skacel M, Lima JM, Andrade CM (1990) Arqu Neuro-Psiqu 48(4):473-477.
40. Ashe KM, et al. (2010) Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe disease. Mol Genet Metab 100(4):309-315.
41. Zhang X, et al. (2011) Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy 7(4):412-425.
42. Tomlinson DR, Gardiner NJ (2008) Glucose neurotoxicity. Nat Rev Neurosci 9(1): 36-45.
43. Rakhit R, et al. (2007) An immunological epitope selective for pathological monomermisfolded SOD1 in ALS. Nat Med 13(6):754-759.
44. Zetterström P, et al. (2007) Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc Natl Acad Sci USA 104(35):14157-14162.
45. Bach JR (1995) Amyotrophic lateral sclerosis: Predictors for prolongation of life by noninvasive respiratory aids. Arch Phys Med Rehabil 76(9):828-832.
46. Sancho J, Servera E, Bañuls P, Marín J (2010) Prolonging survival in amyotrophic lateral sclerosis: Efficacy of noninvasive ventilation and uncuffed tracheostomy tubes. Am J Phys Med Rehabil 89(5):407-411.